James J. O'Donnell III – författare

O’Donnell’s Drug Injury, Fifth Edition presents up-to-date information on adverse events caused by drugs via direct pharmacological action or indirectly through injury caused by impairment or an altered mental state. The impact of drug injury on legal cases is emphasized throughout the book. This book serves as a comprehensive reference for attorneys, pharmacists, physicians, risk managers, nurses, drug manufacturers, and regulators—as well as anyone with an interest in drug use and drug injury. It lays out general pharmacological principles, presents an in-depth discussion of high-risk drugs often implicated in drug injury, details best practices to improve medication safety in clinical pharmacy practice, and discusses a variety of important forensic toxicology concepts such as drug testing.

If you have an involvement with the health care system, you know that drug-induced injury cases are as complex as they are common. While the injury to the patient might seem obvious, in reality that has very little effect on the course that the litigation will take. This makes it especially important to accurately evaluate the case. You''ll want to be sure that the case you take on has merit and will prove economically sound for both you and your client. To successfully accomplish this, you need the knowledge of pharmacy and the drug manufacturing industry that the authors have carefully detailed in this book.

· Pharmacology and toxicology of high-alert and high-risk drugs often implicated in legal cases

· Application of pharmacological and toxicological principles to the law

· Coverage of processes to ensure medication safety, gaps and blind spots in this process, and recommendations on how to enhance drug safety

· Eight new chapters covering timely topics such as Antineoplastics Therapy, Contrast Media Neurotoxicity, Drug Recognition Evaluation, RxISK Adverse Drug Reaction Reporting Program, Compounding Pharmacy Fraud, Involuntary Intoxication, and Total Parenteral Nutrition Errors and Injuries

· Contributions by 43 authors with diverse expertise, including pharmacologists; toxicologists; clinical pharmacists; physicians; attorneys; nephrologists, and a neurologist, hepatologist, epidemiologist, addiction expert, and an investigative health reporter.

O’Donnell’s Drug Injury, Fifth Edition presents up-to-date information on adverse events caused by drugs via direct pharmacological action or indirectly through injury caused by impairment or an altered mental state. The impact of drug injury on legal cases is emphasized throughout the book. This book serves as a comprehensive reference for attorneys, pharmacists, physicians, risk managers, nurses, drug manufacturers, and regulators—as well as anyone with an interest in drug use and drug injury. It lays out general pharmacological principles, presents an in-depth discussion of high-risk drugs often implicated in drug injury, details best practices to improve medication safety in clinical pharmacy practice, and discusses a variety of important forensic toxicology concepts such as drug testing.

If you have an involvement with the health care system, you know that drug-induced injury cases are as complex as they are common. While the injury to the patient might seem obvious, in reality that has very little effect on the course that the litigation will take. This makes it especially important to accurately evaluate the case. You''ll want to be sure that the case you take on has merit and will prove economically sound for both you and your client. To successfully accomplish this, you need the knowledge of pharmacy and the drug manufacturing industry that the authors have carefully detailed in this book.

· Pharmacology and toxicology of high-alert and high-risk drugs often implicated in legal cases

· Application of pharmacological and toxicological principles to the law

· Coverage of processes to ensure medication safety, gaps and blind spots in this process, and recommendations on how to enhance drug safety

· Eight new chapters covering timely topics such as Antineoplastics Therapy, Contrast Media Neurotoxicity, Drug Recognition Evaluation, RxISK Adverse Drug Reaction Reporting Program, Compounding Pharmacy Fraud, Involuntary Intoxication, and Total Parenteral Nutrition Errors and Injuries

· Contributions by 43 authors with diverse expertise, including pharmacologists; toxicologists; clinical pharmacists; physicians; attorneys; nephrologists, and a neurologist, hepatologist, epidemiologist, addiction expert, and an investigative health reporter.